Prelude Therapeutics Inc - ESG Rating & Company Profile powered by AI
The analysis of Prelude Therapeutics Inc leverages information from across the web as well as from available disclosures by Prelude Therapeutics Inc. The article includes a questions and answers table about Prelude Therapeutics Inc. If you are employed by Prelude Therapeutics Inc and you would like to licence your Sustainability aseessment, please contact us.
Prelude Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 1.6 and governance score of 4.8.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1353 | Vera Therapeutics Inc | 2.9 | Medium |
| 1353 | Veracyte Inc | 2.9 | Medium |
| 1393 | Prelude Therapeutics Inc | 2.8 | Medium |
| 1393 | Bioventix PLC | 2.8 | Medium |
| 1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Prelude Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Prelude Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Prelude Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Prelude Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Prelude Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Prelude Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Prelude Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Prelude Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Prelude Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Prelude Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Prelude Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Prelude Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Prelude Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Prelude Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Prelude Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Prelude Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Prelude Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Prelude Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of small molecule therapies optimized to target the key driver mechanisms in cancers. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies in patients who are refractory to or intolerant of established therapies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme and primary central nervous system lymphomas. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; and PRT-K4 that is in preclinical stage for solid tumors. Prelude Therapeutics Incorporated was incorporated in 2016 and is headquartered in Wilmington, Delaware.